Charming Medical Limited
MCTA
$29.36
$1.866.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.20M | 1.04M | 872.20K | 825.00K | 777.80K |
| Total Depreciation and Amortization | 263.60K | 310.60K | 357.60K | 374.60K | 391.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 124.00K | 104.00K | 84.00K | 76.50K | 69.00K |
| Change in Net Operating Assets | -1.16M | -1.14M | -1.13M | -1.04M | -943.20K |
| Cash from Operations | 425.80K | 305.40K | 185.00K | 240.20K | 295.40K |
| Capital Expenditure | -287.40K | -231.10K | -174.80K | -192.70K | -210.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.94M | -971.00K | -- | -- | -- |
| Cash from Investing | -2.23M | -1.20M | -174.80K | -192.70K | -210.60K |
| Total Debt Issued | 205.80K | 129.00K | 52.20K | 45.30K | 38.40K |
| Total Debt Repaid | -157.00K | -146.40K | -135.80K | -145.00K | -154.20K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 472.40K | 1.05M | 1.62M | 919.60K | 216.00K |
| Cash from Financing | 521.20K | 1.03M | 1.54M | 819.70K | 100.00K |
| Foreign Exchange rate Adjustments | -4.60K | -19.90K | -35.20K | -22.80K | -10.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.29M | 113.80K | 1.51M | 844.40K | 174.40K |